Ellipsys Vascular Access System Post Market Surveillance (PS) Study
NCT: NCT04484220 · COMPLETED
NCT IDNCT04484220
StatusCOMPLETED
Start Date2021-04-13
Completion2025-03-31
Brief Summary
The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.
Frequently Asked Questions
What is Ellipsys Vascular Access System Post Market Surveillance (PS) Study?
Ellipsys Vascular Access System Post Market Surveillance (PS) Study is a clinical trial registered under NCT04484220. Current status: COMPLETED.
What is the status of NCT04484220?
The current status of NCT04484220 (Ellipsys Vascular Access System Post Market Surveillance (PS) Study) is: COMPLETED.
When did Ellipsys Vascular Access System Post Market Surveillance (PS) Study start?
Ellipsys Vascular Access System Post Market Surveillance (PS) Study started on 2021-04-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.